Search Results 381-390 of 15912 for pharmacogenetics
For more information and all your COVID-19 coverage, go to the Mayo Clinic News Network and mayoclinic.org. Largest pharmacogenetic clinical trial in ...
Drugs used in chemotherapy, such as lenalidomide and dexamethasone, work in different ways to stop the growth of tumor cells, either by killing the cells, by ...
The Human Genome Project was launched in 1990 to determine the DNA sequence of the entire human genome. Since its completion in 2003, the project has paved ...
About this study. The purpose of this study is to develop a resource (bank) of biospecimens and data collected from individuals with functional ...
The Pharmacology Shared Resource provides preclinical and clinical pharmacokinetic, pharmacodynamic and pharmacogenetic expertise, methodologies and ...
About this study. Specific mutations relating to hyperoxaluria will be determined via DNA analysis by the Mayo RKSC research staff.
Rochester, Minn., Jacksonville, Fla., Scottsdale/Phoenix, Ariz. The purpose of this study is to collect vaginal and endometrial cell samples to study ...
This study aims to investigate the utility of using plasma DNA methylation to detect measurable residual disease or early recurrence/progression of patients ...
This is a multi-center, open-label trial of orally administered CA-4948 monotherapy in adult patients with Relapsed or Refractory NHL. The trial will be ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift to our 2025 Drive to Cure Cancer and transform the way cancer is treated and defeated.